Cargando…
Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacteria...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614664/ https://www.ncbi.nlm.nih.gov/pubmed/37908670 http://dx.doi.org/10.2147/IJN.S427055 |
_version_ | 1785129068894617600 |
---|---|
author | Huang, Xiaofei Shi, Lihua Lin, Yin Zhang, Cong Liu, Penghui Zhang, Ran Chen, Qiqi Ouyang, Xudong Gao, Yuanyuan Wang, Yingshuai Sun, Tongyi |
author_facet | Huang, Xiaofei Shi, Lihua Lin, Yin Zhang, Cong Liu, Penghui Zhang, Ran Chen, Qiqi Ouyang, Xudong Gao, Yuanyuan Wang, Yingshuai Sun, Tongyi |
author_sort | Huang, Xiaofei |
collection | PubMed |
description | PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacterial infections. This study aims to synthesize a comprehensive therapeutic material using polysaccharides from Pycnoporus sanguineus to promote DFU wound healing, reduce ROS levels, and minimize bacterial infections. METHODS: Polysaccharides from P.sanguineus were employed as reducing and stabilizing agents to fabricate polysaccharide-based composite particles (PCPs) utilizing silver ions as templates. PCPs were characterized via UV-Vis, TEM, FTIR, XRD, and DLS. The antioxidant, antimicrobial, and cytotoxic properties of PCPs were assessed through in vitro and cellular experiments. The effects and mechanisms of PCPs on wound healing were evaluated using a diabetic ulcer mouse model. RESULTS: PCPs exhibited spherical particles with an average size of 57.29±22.41 nm and effectively combined polysaccharides’ antioxidant capacity with silver nanoparticles’ antimicrobial function, showcasing synergistic therapeutic effects. In vitro and cellular experiments demonstrated that PCPs reduced cellular ROS levels by 54% at a concentration of 31.25 μg/mL and displayed potent antibacterial activity at 8 μg/mL. In vivo experiments revealed that PCPs enhanced the activities of superoxide dismutase (SOD) and catalase (CAT), promoting wound healing in DFUs and lowering the risk of bacterial infections. CONCLUSION: The synthesized PCPs offer a novel strategy for the comprehensive treatment of DFU. By integrating antioxidant and antimicrobial functions, PCPs effectively promote wound healing and alleviate patient suffering. The present study demonstrates a new strategy for the integrated treatment of diabetic wounds and expands the way for developing and applying the polysaccharide properties of P. sanguineus. |
format | Online Article Text |
id | pubmed-10614664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106146642023-10-31 Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy Huang, Xiaofei Shi, Lihua Lin, Yin Zhang, Cong Liu, Penghui Zhang, Ran Chen, Qiqi Ouyang, Xudong Gao, Yuanyuan Wang, Yingshuai Sun, Tongyi Int J Nanomedicine Original Research PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacterial infections. This study aims to synthesize a comprehensive therapeutic material using polysaccharides from Pycnoporus sanguineus to promote DFU wound healing, reduce ROS levels, and minimize bacterial infections. METHODS: Polysaccharides from P.sanguineus were employed as reducing and stabilizing agents to fabricate polysaccharide-based composite particles (PCPs) utilizing silver ions as templates. PCPs were characterized via UV-Vis, TEM, FTIR, XRD, and DLS. The antioxidant, antimicrobial, and cytotoxic properties of PCPs were assessed through in vitro and cellular experiments. The effects and mechanisms of PCPs on wound healing were evaluated using a diabetic ulcer mouse model. RESULTS: PCPs exhibited spherical particles with an average size of 57.29±22.41 nm and effectively combined polysaccharides’ antioxidant capacity with silver nanoparticles’ antimicrobial function, showcasing synergistic therapeutic effects. In vitro and cellular experiments demonstrated that PCPs reduced cellular ROS levels by 54% at a concentration of 31.25 μg/mL and displayed potent antibacterial activity at 8 μg/mL. In vivo experiments revealed that PCPs enhanced the activities of superoxide dismutase (SOD) and catalase (CAT), promoting wound healing in DFUs and lowering the risk of bacterial infections. CONCLUSION: The synthesized PCPs offer a novel strategy for the comprehensive treatment of DFU. By integrating antioxidant and antimicrobial functions, PCPs effectively promote wound healing and alleviate patient suffering. The present study demonstrates a new strategy for the integrated treatment of diabetic wounds and expands the way for developing and applying the polysaccharide properties of P. sanguineus. Dove 2023-10-26 /pmc/articles/PMC10614664/ /pubmed/37908670 http://dx.doi.org/10.2147/IJN.S427055 Text en © 2023 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Huang, Xiaofei Shi, Lihua Lin, Yin Zhang, Cong Liu, Penghui Zhang, Ran Chen, Qiqi Ouyang, Xudong Gao, Yuanyuan Wang, Yingshuai Sun, Tongyi Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title | Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title_full | Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title_fullStr | Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title_full_unstemmed | Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title_short | Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy |
title_sort | pycnoporus sanguineus polysaccharides as reducing agents: self-assembled composite nanoparticles for integrative diabetic wound therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614664/ https://www.ncbi.nlm.nih.gov/pubmed/37908670 http://dx.doi.org/10.2147/IJN.S427055 |
work_keys_str_mv | AT huangxiaofei pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT shilihua pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT linyin pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT zhangcong pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT liupenghui pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT zhangran pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT chenqiqi pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT ouyangxudong pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT gaoyuanyuan pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT wangyingshuai pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy AT suntongyi pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy |